Skip to content

Verona Pharma PLC Sustainability Reports

Verona Pharma plc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of chronic respiratory diseases, primarily chronic obstructive pulmonary disease (COPD).

Sector: Professional & technical services

Country: United Kingdom

Exchange: Nasdaq

LEI: 213800EVI6O6J3TIAL06

FIGI: BBG00GD4KBM0

6 reports from 2019 to 2024